Literature DB >> 2934477

The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.

D L Thiele, P E Lipsky.   

Abstract

L-Leucyl-L-leucine methyl ester (Leu-Leu-OMe), a dipeptide condensation product of L-leucine methyl ester generated by human monocytes (M phi) or polymorphonuclear leukocytes, eliminates all natural killer cell (NK) function from mixed lymphocyte populations. In the present studies, the specificity of the action of Leu-Leu-OMe was examined. It was found that a variety of tissue culture cells and tumor lines of nonlymphoid origin were completely resistant to any demonstrable Leu-Leu-OMe-mediated toxicity. Furthermore, the erythroleukemia line K562, the T cell line Molt-4, the B cell lines HS-Sultan and Daudi, and EBV-transformed B cell lines were unaffected by concentrations of this compound that completely eliminated NK cells. Similarly, the vast majority of OKT4+ lymphocytes manifested no significant toxicity after Leu-Leu-OMe exposure. Furthermore, they retained the capacity to proliferate normally in response to allogeneic cells as well as the ability to provide help for the generation of immunoglobulin-secreting cells (ISC). However, Leu-Leu-OMe caused partial depletion of OKT8+ cells from mixed populations of lymphocytes. After such exposure, the remaining OKT8+ cells were still capable of proliferating in mixed lymphocyte cultures, but the suppressive effect of these cells on ISC generation was abolished. Furthermore, both precursors and activated effectors of cytotoxic T lymphocyte (CTL) and activated NK-like activity generated in mixed lymphocyte cultures were eliminated by exposure to low concentrations of Leu-Leu-OMe. Indeed, both OKT4+ and OKT8+ CTL were eliminated by Leu-Leu-OMe. In addition, both peripheral blood M phi and U937 cells, a human cell line with many M phi-like characteristics, were sensitive to Leu-Leu-OMe-mediated toxicity, although only at two- to fivefold higher concentrations than those completely eliminating NK cells. These findings indicate that Leu-Leu-OMe has selective toxicity for NK cells, CTL, and M phi without adverse effects on a variety of other lymphoid or nonlymphoid cell types.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2934477

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway.

Authors:  Fabio Rabelo Melo; Ida Waern; Elin Rönnberg; Magnus Åbrink; David M Lee; Susan M Schlenner; Thorsten B Feyerabend; Hans-Reimer Rodewald; Boris Turk; Sara Wernersson; Gunnar Pejler
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

2.  In vitro immunization can elicit the expansion of diverse repertoire of B cells from peripheral blood mononuclear cells.

Authors:  Shin-Ei Matsumoto; Makiko Yamashita; Yoshinori Katakura; Eri Noguchi; Yoshihiro Aiba; Akira Ichikawa; Kiichiro Teruya; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2006-09-05       Impact factor: 2.058

3.  Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells.

Authors:  D L Thiele; P E Lipsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopes.

Authors:  P Ifversen; C Mårtensson; L Danielsson; C Ingvar; R Carlsson; C A Borrebaeck
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

5.  Discordant phenotype in siblings with X-linked agammaglobulinemia.

Authors:  M J Bykowsky; R N Haire; Y Ohta; H Tang; S S Sung; E S Veksler; J M Greene; S M Fu; G W Litman; K E Sullivan
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

6.  The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes.

Authors:  M Ohlin; L Danielsson; R Carlsson; C A Borrebaeck
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

7.  Human T cell responses to beta-galactosidase.

Authors:  J D Oxley; R H Brookes; L S Rayfield; P S Shepherd
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

8.  Prevention of lethal murine graft versus host disease by treatment of donor cells with L-leucyl-L-leucine methyl ester.

Authors:  M Charley; D L Thiele; M Bennett; P E Lipsky
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

9.  Development of the cell contact-mediated accessory function for T-cell proliferation in a human promyelocytic leukaemia cell line, HL-60, by 1,25-dihydroxyvitamin D3.

Authors:  T Shinbori; M Yamada; K Kakimoto; S Araki; K Onoue
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

10.  Generalized toxicity of L-leucyl-leucine-methyl ester for lymphocyte functions.

Authors:  A M Mowat; P A Leck
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.